A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn’t benefit the vast majority of patients and may contribute to a higher risk of ...
New Delhi: Beta blockers, the standard treatment after a heart attack for the last 40 years, may offer no benefit for heart attack patients and can raise death risk in some women, according to a study ...